St. Cloud Surgical Center is First ASC in U.S. to Utilize Xenex Germ-Zapping Robot to Disinfect Operating Rooms & Enhance Patient Safety more

4 cheap small cap stocks I’ve got my eye for Christmas more

Southern Biologics Network Established to Create Biologics Faster and Less Expensively more

Morningside Ministries at the Manor is the First Skilled Nursing Facility in Texas to Protect Residents with Xenex Germ-Zapping Robot more

RBA to cut rates in 2015: Still want to invest in term deposits? more

Can robots help stop the Ebola outbreak? more

Robots Help Fight Ebola more

South Florida Hospital Unveils Ebola-Zapping Robot more

Sonoma Valley Hospital uses robot to kill germs more

Robots go to war against Ebola more

New iTraumaCare CEO to pursue big growth more

UAB and SRI have plans to spinoff more success more

Launch of Galderma's new acne products more

iTraumaCare’s new CEO to help company secure new funding more

U.S. Air Force Hospital Langley Adds Xenex Ebola-Zapping Robot to Inventory more

Forthcoming Acne Treatment Made With Exclusive (And Sustainable) East Indian Sandalwood Oil more

Sonoma Valley Hospital Acquires Xenex Germ-Killing Robot to Enhance Patient Safety more

Robot fights germs at Sharp Chula Vista Medical Center more

Xenex updates protocols for germ-zapping robots in response to Ebola threat more

How do we get rid of the endotoxins? Birmingham's  has the solution more

Medical Device ® Positions New Leader for Next-Level Growth more

The Xenex robot at South Shore Hospital featured on an Xploration Earth more

Germ-zapping robot Gigi sets its sights on Ebola more

Morningside Ventures leads a Series B round for DNAtrix more

StemBioSys secures new research space at BioBridge Global more

Birmingham's Soluble Therapeutics acquires Seattle company Dilyx Biotechnology more

Company invents germ-zapping robot more

Xenex Congratulates Houston Cancer Hospital more

Australian grown Indian Sandalwood timber attracts lucrative Asian markets more

DNATRIX ANNOUNCES TREATMENT OF FIRST PATIENT WITH DNX-2401 more

Targeted Technology raises more than $40 million more

Reducing Healthcare Associated Infections (HAIs): Not All UV Light is the Same more

Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO more

Three Birmingham companies recognized in PwC report more

Former Kinetic Concepts Inc. CEO to lead StemBioSys more

International dermatology company Galderma confirmed more

AUSTRALIAN Sandalwood producer TFS Corporation will supply oil more

San Antonio luring biotech firms with venture capital more

Biotech firm secures nearly $5 million in funding, is relocating to San Antonio more

Birmingham is on the front lines of medical research: take a look at this incredible biotech startup

I went to Soluble Therapeutics this morning, a trip I've been looking forward to for a couple of weeks. It's located at Innovation Depot, which you can find on my #bhamtech public map here. 
I met with John McCarter, who I've known for a while now. He's the Director of Business Development at this booming company and a great guy, all around.

John was born in Memphis, TN but spent most of his formative years in Virginia.

He went to Virginia Tech first and achieved an undergraduate degree in Marketing with a minor in Spanish.

He moved to Alabama with family in 2007 and went to work at the University of West Alabama while also completing another undergraduate degree, this time in chemistry.

In 2009 he landed in Birmingham and completed a masters degree in Biotechnology by 2011. Before he graduated, he went to work for Soluble Therapeutics as a lab intern. He moved to the business side of the company in 2012. 

Let's talk about Soluble Therapeutics for a minute, because their technology is genuinely amazing:

What do they do? 
Soluble Therapeutics is a biotechnology company that has developed a completely original method of optimizing protein solutions for use in many different industries, especially in the medical field.

Proteins are kind of finicky and don't do well in solutions. They tend to break down by destructively bumping into one another until the solution is useless. We need to find ways of keeping the proteins in good shape for long periods of time so that they are effective when they are delivered. And we need reliable methods of testing these solutions to make sure of this.   

Soluble Therapeutics' method is incredibly efficient as compared to other methods of protein solution diagnostics. Literally saving the companies and institutions that use their tools and services hundreds of thousands of dollars and untold amounts of time, but returning just as reliable results.

Why this is important? 
Biologics, some believe, is the future of medical treatment. Soluble Therapeutics' technology makes the reliable testing of those treatments much faster and cheaper than previous methods. In other words, they're making the future of medicine happen faster. And they're doing it right down the road on 1st Avenue North.

Proteins?
Yes, proteins.

To state it simply: every function in your body is the result of proteins carrying out the instructions of DNA (you remember DNA, right?). Sometimes, those proteins malfunction. That malfunctioning of proteins is what we call 'disease'. Cancer is a great example of protein malfunctions gone crazy.

John wrapped it up this way: "Biologics are the fastest growing type of pharmaceuticals in development - as we learn more about the biology of certain diseases and the protein signaling pathways associated with each pathology, more protein-based interventions will definitely make it to market."

These folks are on the cutting edge of that development.

Soluble Therapeutics are a spin-off startup of the research being done at UAB's Center for Biophysical Sciences and Engineering(CBSE), which is also on the #bhamtech public map. More on Soluble Therapeutics as well as some of the stuff going on at the CBSE, coming soon.

www.soluble-therapeutics.com back

Germ-Zapping Robots Fight C. diff and MRSA at Mercy Health Saint Mary's more

Milford hospital enlists robots in war against infections more

Xenex Testifies About UV Room Disinfection Technology Effectiveness to U.S. House of Representatives more

Western Pa. hospitals test robot using ultraviolet rays to kill bacteria more

Xenex Demonstrates UV Room Cleaning System’s Effectiveness in Reducing Hospital Acquired Infections more

TFS flags record full-year profit more

Sweet scented sandalwood flavour of month more

House committee looks for new technology in Veterans Affairs hospitals more

FDA grants fast track status to drug DNX-2401 for recurrent Glioblastoma more

CEO shakeup at San Antonio biotech company StemBioSys more

First harvest to be completed in June more

BiO2 Medical Enrolls Subjects in the New U.S. FDA Early Feasibility Pilot Study for the Angel® Catheter more

San Antonio biotech firm readies skin treatment for distribution more

ViroXis Gets Approval To Initiate FDA Phase 2 Study For Molluscum Contagiosum more

Medical technologies conference announces speaker lineup more

Australian sandalwood sells for millions more

Sandalwood exports as good as gold more

Santalis Pharmaceuticals Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize OTC Dermatology Products more

ViroXis Corporation Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize an OTC Dermatology Product more

DNAtrix Awarded $10.8 Million Grant by the Cancer Prevention and Research Institute of Texas more

ViroXis Corporation Achieves Key Clinical Milestones more

There are growing concerns about the threat of an antibiotic crisis caused by the spread of drug-resistant superbugs. Those concerns could result in more